Specifically, this analysis revealed a TP53 somatic mutation frequency of 6.3% in the CA MM cases compared to 1.6% in AA MM cases (p = 0.035) (Fig 3, Table 1, S2 Fig, S4 Table). The gene discussed is TP53; the disease is Miyoshi myopathy.